Reported 4,939,931 shares, unchanged from the prior quarter.
Reported value -23.7%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 3822000 |
| 2022-03-31 | 12666000 |
| 2022-06-30 | 21242000 |
| 2022-09-30 | 15956000 |
| 2022-12-31 | 5582122 |
| 2023-03-31 | 6471310 |
| 2023-06-30 | 4939931 |
| 2023-09-30 | 5335125 |
| 2023-12-31 | 3655549 |
| 2024-03-31 | 4791733 |
| 2024-06-30 | 3260354 |
| 2024-09-30 | 4396539 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2024 | Unchanged | 4,939,931 | 0 (0.0%) | 20.1% | $4,396,539 | 2024-10-18 | |
| Q2 2024 | Unchanged | 4,939,931 | 0 (0.0%) | 14.06% | $3,260,354 | 2024-08-13 | |
| Q1 2024 | Unchanged | 4,939,931 | 0 (0.0%) | 20.73% | $4,791,733 | 2024-04-30 | |
| Q4 2023 | Unchanged | 4,939,931 | 0 (0.0%) | 20.25% | $3,655,549 | 2024-02-14 | |
| Q3 2023 | Unchanged | 4,939,931 | 0 (0.0%) | 25.51% | $5,335,125 | 2023-11-13 | |
| Q2 2023 | Unchanged | 4,939,931 | 0 (0.0%) | 16.97% | $4,939,931 | 2023-08-11 | |
| Q1 2023 | Unchanged | 4,939,931 | 0 (0.0%) | 17.03% | $6,471,310 | 2023-05-10 | |
| Q4 2022 | Unchanged | 4,939,931 | 0 (0.0%) | 8.41% | $5,582,122 | 2023-02-10 | |
| Q3 2022 | Unchanged | 4,939,931 | 0 (0.0%) | 18.21% | $15,956,000 | 2022-11-14 | |
| Q2 2022 | Added | 4,939,931 | +3,074,519 (164.8%) | 23.35% | $21,242,000 | 2022-08-15 | |
| Q1 2022 | Added | 1,865,412 | +1,506,262 (419.4%) | 7.87% | $12,666,000 | 2022-05-16 | |
| Q4 2021 | New | 359,150 | +359,150 (0.0%) | 2.55% | $3,822,000 | 2022-02-11 |
Who else reported the position
35 managers reported RAPID MICRO BIOSYSTEMS INC for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors LLC | Unchanged | 8,434,560 | 0 | 0.87% | $8,434,560 | 8 qtrs |
| KENNEDY LEWIS MANAGEMENT LP This report | Unchanged | 4,939,931 | 0 | 16.97% | $4,939,931 | 7 qtrs |
| JPMorgan Chase & Co | Reduced | 1,435,707 | -19,454 | < 0.01% | $1,435,707 | 8 qtrs |
| GLENVIEW CAPITAL MANAGEMENT LLC | Added | 1,318,288 | +500,000 | 0.03% | $1,318,288 | 6 qtrs |
| ABG-WTT Global Life Science Capital Partners GP Ltd | Unchanged | 1,038,296 | 0 | 18.84% | $1,038,296 | 6 qtrs |
| BlackRock Inc | Added | 1,034,861 | +7,801 | < 0.01% | $1,034,861 | 8 qtrs |
| The Goldman Sachs Group Inc | Reduced | 941,357 | -2,983 | < 0.01% | $941,357 | 8 qtrs |
| VANGUARD GROUP INC | Unchanged | 729,600 | 0 | < 0.01% | $729,600 | 8 qtrs |
| ADAGE CAPITAL PARTNERS GP L L C | Unchanged | 700,000 | 0 | < 0.01% | $700,000 | 8 qtrs |
| KHAZANAH NASIONAL BERHAD | Unchanged | 648,905 | 0 | 0.14% | $648,905 | 6 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 11, 2023
- Filing type
- 13F-HR
- Position type
- CLASS A COM
Voting authority reported
- Sole
- 4,939,931
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.